Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Ozempic (semaglutide ... section later in this article. Note: After the Food and Drug Administration (FDA) approves a drug, it tracks and reviews side effects of the medication.

It has expanded its offerings to include weight loss, focusing on prescription medications, including its own compounded semaglutide GLP ... products are available after signing up for the service ...

Under medical supervision, GLP-1 agonists often lead to safe, sustainable weight loss, as noted in clinical reviews ... daily before meals. The dose may be increased to 10 mcg after 1 month ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

In response to complaints made publicly by the Partnership for Safe Medicine and the Obesity Society, Hims & Hers provided ...

The first clinical trial of its kind found the weekly jab semaglutide, also known as Ozempic ... The new study comes after UK figures published last week showed deaths from alcohol have reached ...